Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Multivariate model analysis, including T2D status, age, and body mass index (BMI), displayed significant covariance in PPARGC-1α rs8192678; SIRT1 rs7896005; TCF7L2 rs7903146 and rs122243326; UCP3 rs3781907; and HHEX rs1111875 with a P < 0.05. 31759989

2020

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE In the subgroup analysis, we identified a significant association between PGC-1<i>α</i> rs8192678</span> polymorphism and T2DM in the Caucasian and Indian populations under all genetic models we investigated. 30944665

2019

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The aim of this study was to analyse the association between PPARG rs1801282, PPARGC1A rs8192678, VEGFA rs2010963, ADRA2A rs553668, KCNQ1 rs2237892, SIRT1 rs7896005, IGF2BP2 rs4402960, and UCP3 rs3781907 single nucleotide variants (SNVs) with T2D and metabolic traits in a case-control study of a population from Mexico City. 29800730

2018

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Meta-analyses conducted on rs8192678 and rs2970847 variants illustrated the overall effect of minor alleles providing a higher risk for the T2D development. 29063962

2018

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE All polymorphisms were in Hardy-Weinberg equilibrium, and the association by genotype with T2D-related traits displayed nominal significance for rs8192678 with glucose (<i>p</i> = 0.023) and triglycerides (<i>p</i> = 0.013); rs2010963 with diastolic blood pressure (DBP) (<i>p</i> = 0.012) and cholesterol (<i>p</i> = 0.013); rs7896005 with DBP (<i>p</i> = 0.012) and insulin (<i>p</i> = 0.011); and rs659366 with cholesterol (<i>p</i> = 0.034), glucose (<i>p</i> = 0.031) and triglycerides (<i>p</i> = 0.028); and the association of rs2010963 with HDL-C (<i>p</i> = 0.0007) was significant. 30393491

2018

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE A single nucleotide variant of the PPARGC1A gene (rs8192678) is associated with T2D susceptibility, relative risk of obesity and insulin resistance, and lower indices of β cell function. 29186342

2018

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Haplotype comparison analysis indicated that CTTCGGG and CTCTGGG haplotypes with the order of PPARG rs1801282 C>G, PPARG rs3856806 C>T, PPARGC1A rs8192678 C>T, PPARGC1A rs2970847 C>T, PPARGC1A rs3736265 G>A, PPARGC1B rs7732671 G>C and PPARGC1B rs17572019 G>A polymorphisms in gene position significantly increased the risk of T2DM. 28418876

2017

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Using a range of Polynesian populations (Tongan, Māori, Samoan) we re-examined evidence for association between Gly482Ser with T2D and BMI as well as gout. 27846814

2016

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Our findings revealed significant associations between PGC-1alpha Gly482Ser and Thr528Thr polymorphisms and type 2 diabetes in Kurdish-Iranians. 25282005

2015

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Under an additive genetic model, the C allele of ADRB3-rs4994, the C allele of ENPP1-rs1044498, and the A allele of PPARGC1A-rs8192678 increase the risk of type 2 diabetes in the Chinese Han population. 22391941

2012

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Association of the PGC-1α rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitus. 22684233

2012

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE This meta-analysis indicated that Gly482Ser and Thr394Thr polymorphisms of PPARGC1A gene were significantly associated with the risk of T2DM, especially in the Indian population. 21294239

2011

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE In this series, there was no association between G482S polymorphism and T2DM and obesity (body mass index >25 kg/m(2)). 19913841

2010

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE These data suggest that the PGC-1α Thr394Thr and Gly482Ser polymorphisms are associated with therapeutic efficacy of multiple-dose rosiglitazone in Chinese patients with type 2 diabetes mellitus. 20498286

2010

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus. 20045142

2010

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Together, these results showed that PPARG Pro12Ala and PPARGC1A Gly482Ser variants are associated, alone and in interaction, with insulin and glucose homeostasis and suggest that gene-gene interactions should be taken into account in candidate gene studies of T2DM to identify subjects with markedly different risks of developing the disease. 19536736

2009

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE We therefore investigated if PPARGC1A expression is altered in islets from patients with type 2 diabetes and whether this expression is influenced by genetic (PPARGC1A Gly482Ser polymorphism) and epigenetic (DNA methylation) factors. 18270681

2008

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Genetic studies have suggested that Gly482Ser polymorphism of the PGC-1alpha gene is associated with a higher risk of type 2 diabetes, obesity, and hypertension. 18614852

2008

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The objective of this case-control study was to explore the relationship between SNPs of PGC-1alpha and type 2 diabetes in the southern Chinese population and to determine whether the common variants: Gly482Ser and Thr394Thr, in the PGC-1alpha gene have any impacts on interaction with myocyte enhancer factor (MEF) 2C. 18067759

2007

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The variant allele of the Gly482Ser polymorphism in peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PPARGC1A or PGC1alpha), a critical determinant of skeletal muscle metabolism, has been associated with obesity and type 2 diabetes. 16474966

2006

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE This meta-analysis of data from the current and published studies supports a modest role for the Gly482Ser PPARGC1A variant in type 2 diabetes risk. 16435105

2006

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The Ser/X genotype of the Gly482Ser polymorphism in the PPARGC1 gene appears to be a risk factor for T2DM in northern Chinese men. 16978372

2006

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE Recent studies suggested linkage between the chromosomal region of PGC-1alpha and fasting serum insulin levels, and associates a Gly482Ser polymorphism of the gene with type 2 diabetes and hypertension. 15649578

2005

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The present study demonstrates that the AA genotype of the Gly482Ser polymorphism in the PPARGC1 gene might be a risk factor for diabetic retinopathy in the Slovene population (Caucasians) with type 2 diabetes (odds ratio 2.7, 95% confidence interval 1.0-6.8), whereas the Pro12Ala polymorphism of the PPARgamma gene failed to confer susceptibility to diabetic retinopathy. 15782399

2005

dbSNP: rs8192678
rs8192678
0.100 GeneticVariation BEFREE The objective of the present investigation was to examine the relationship of three polymorphisms, Thr394Thr, Gly482Ser and +A2962G, of the peroxisome proliferator activated receptor-gamma co-activator-1 alpha (PGC-1alpha) gene with Type 2 diabetes in Asian Indians. 16241916

2005